LumaMed’s patented technology, LumaScan™, helps assure both surgeons and patients that “they got it all” during cancer surgery. LumaScan provides intraoperative ex-vivo tissue imaging useful in many cancers, including Breast Conservation Surgery (BCS; lumpectomy), oral cancer and skin cancer. LumaScan is a table-top system designed to hold a proprietary disposable tray outfitted with a calibration target and an optical window. The device functions as an inverted microscope and is a Class 1 device exempt from FDA 510(k) clearance requirements. Our innovative technology uses polarized light to exclusively image the superficial layers of tissue, i.e. layer that must be free of cancer for successful cancer surgery It is a low risk procedure in that all tissue samples will continue to be evaluated by conventional histopathology for definitive analysis. LumaMed technology is the subject of seven (7) issued licensed U.S. patents, several foreign patents and additional pending applications.